Sticker shock for health care in America has been a growing concern for decades in the United States. From prescription drugs to lab tests, durable medical equipment, outpatient surgery, and hospital stays, Americans increasingly feel they pay through the roof for medical care.

As chairman of the U.S. Senate Finance Committee, I’ve worked to bring transparency to the policymaking tables to expose wrongdoing, increase accountability, drive up quality and drive down costs. Specifically, I support anti-kickback and sunshine laws that protect taxpayers and put patients first. My open payments law created a federal database that requires health care providers to disclose financial payments from pharmaceutical companies and medical device manufacturers.

Last year I secured expansions to include nurse practitioners and physician assistants. When health care providers prescribe medication or recommend a particular therapy or treatment, consumers ought to know about financial relationships between them and the industry.

For decades, a veil of secrecy has shrouded increasingly complex pricing arrangements negotiated between doctors, hospitals, insurers and benefit managers. For taxpayers who underwrite subsidized insurance and foot the bill for public health care programs and patients who pay steep out-of-pocket costs for medical care, improving transparency in the U.S. health care system is a big deal. It’s a policy goal worth the growing pains it will take to get it right. Unraveling the whole ball of wax to make pricing information user-friendly for consumers is a tall order.

The bottom line is clear. Americans are fed up with the secrecy that allows soaring health care costs, sky-high prescription drug prices and surprise medical bills to keep climbing.

Reforms That Are Underway

I’m glad to see the Trump administration continue its efforts to bring transparency to the murky pricing system in the health care marketplace. So far this year, it has required hospitals to post list prices for their health care services and announced regulations for drug companies to disclose the list price of prescription drugs in television advertisements.

I’ve re-introduced bipartisan legislation I wrote with Sen. Dick Durbin that would require pharmaceutical companies to list prices of drugs in direct-to-consumer ads. President Trump in June also signed an executive order to pull back the curtain on secrecy so consumers and taxpayers have a better understanding about the prices they’re paying for services provided.

In the coming months, the U.S. Department of Health and Human Services will roll out federal rules to help unleash free market forces and drive down costs. Like doctors who take the Hippocratic Oath, it’s important policymakers take care to first, do no harm and to avoid unintended market distortions. For example, mandating price disclosure on negotiated rates should not be leveraged by providers and insurers to collectively bid up their rates. That would defeat the utility of transparency to help bring accountability.

Clear, meaningful information should be used to help boost competition, drive innovation and drive down prices. Unleashing government interference willy-nilly is the wrong remedy to solve soaring prices. That’s why I’m working to steer market-driven reforms that put patients in the driver’s seat and put the brakes on secrecy.

Price disclosure should help root out cost-shifting and expose artificially inflated prices that grow the taxpayer tab and gouge consumers. Secrecy provides cover for insurers, providers, drug companies and benefit managers to milk the rebate system and pad their bottom lines. For too long, patients and taxpayers have been caught in the middle.

The debate on price transparency can be a game changer in the health care marketplace. Consider how the retail landscape has changed for consumers in the market to buy a car. Many buyers can get a better price because they can research and compare information on what price would be reasonable to pay. It should be no different in healthcare.

Transparency brings accountability and better prices. Getting the rules right on price disclosure is important to help make health care more affordable for more Americans and the taxpaying public.

Get CT In Your Inbox!

Don't miss a single update.

You May Also Like

U.S. Dept. of Health and Human Services Issues Three Pro-Life Announcements

The U.S. Department of Health and Human Services issued three pro-life announcements, including two rules dealing with the Obamacare contraceptives mandate.

Grassley To Become Senate President Pro Tempore

U.S. Senator Chuck Grassley (R-Iowa) is set to become the next President Pro Tempore of the U.S. Senate that is 3rd in the line of presidential succession.

Trump Administration Cancels Research Using Fetal Tissue from Abortions

The U.S. Department of Health and Human Services (HHS) announced they were discontinuing the use of fetal tissue procured from elective abortions.

Senate Judiciary Committee Dems Show More Anti-Religious Bigotry

U.S. Senators Kamala Harris (D-CA) and Mazie Hirono (D-HI) raised concerns this month over Brian C. Buescher’s membership in the Knights of Columbus.